Advanced Accelerator Applications S.A. Change in other assets and liabilities

Change in other assets and liabilities of AAAP for past 10 years: annual, quarterly and twelve month trailing (TTM) including Change in other assets and liabilities growth rates and interactive chart.


Highlights and Quick Summary

  • Change in other assets and liabilities for the quarter ending September 29, 2017 was $2.83 Million (a 222.91% increase compared to previous quarter)
  • Year-over-year quarterly Change in other assets and liabilities decreased by -63.22%
  • Annual Change in other assets and liabilities for 2016 was $2.71 Million (a -457.41% decrease from previous year)
  • Annual Change in other assets and liabilities for 2015 was $-760 Thousand (a -701.82% decrease from previous year)
  • Twelve month Change in other assets and liabilities ending September 29, 2017 was $9.1 Million (a -1.71% decrease compared to previous quarter)
  • Twelve month trailing Change in other assets and liabilities increased by 235.19% year-over-year
Trailing Change in other assets and liabilities for the last four month:
29 Sep '17 29 Jun '17 30 Mar '17 30 Dec '16
$9.1 Million $9.26 Million $4.21 Million $2.71 Million
Visit stockrow.com/AAAP for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Change in other assets and liabilities of Advanced Accelerator Applications S.A.

Most recent Change in other assets and liabilitiesof AAAP including historical data for past 10 years.

Interactive Chart of Change in other assets and liabilities of Advanced Accelerator Applications S.A.

Advanced Accelerator Applications S.A. Change in other assets and liabilities for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2017 $2.83 $0.88 $-2.3
2016 $7.69 $2.99 $-4.17 $-3.8 $2.71
2015 $-0.01 $-0.79 $-0.76
2014 $0.13

Business Profile of Advanced Accelerator Applications S.A.

Sector: Medical
Industry: Drugs